另一个是瑞士的试验。在这个实验中，医生给疾病晚期的病人精神治疗的同时让其服用LSD，帮助他们治疗临近死亡所带来的极深的焦虑。
The other is a Swiss trial in which the drug is give alongside psychotherapy to people who have a terminal condition to help them cope with the profound anxiety brought on by impending death.
在发生晚期和极晚期ST的患者中，双重抗血小板的应用比例分别占57%和36%。
Among those with late and very late ST, the prevalence of dual-antiplatelet therapy was 57% and 36%, respectively.
应用推荐